Palanikumar Balasubramanian

Title: Innovations by Palanikumar Balasubramanian

Introduction

Palanikumar Balasubramanian is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of integrin inhibitors. With a total of two patents to his name, his work is recognized for its potential impact on various medical conditions.

Latest Patents

His latest patents focus on 3-substituted propionic acids as αV integrin inhibitors. The present invention provides compounds of Formula (I) or stereoisomers, tautomers, or pharmaceutically acceptable salts or solvates thereof, wherein all the variables are as defined herein. These compounds serve as antagonists to α-containing integrins. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating diseases, disorders, or conditions associated with dysregulation of α-containing integrins. Such conditions include pathological fibrosis, transplant rejection, cancer, osteoporosis, and inflammatory disorders, which can be addressed using these compounds and pharmaceutical compositions.

Career Highlights

Palanikumar Balasubramanian is currently employed at Bristol-Myers Squibb Company, where he continues to innovate and contribute to the pharmaceutical industry. His work is characterized by a commitment to advancing medical science and improving patient outcomes.

Collaborations

Some of his notable coworkers include Guohua Zhao and Pratik Devasthale, with whom he collaborates on various projects within the company.

Conclusion

Palanikumar Balasubramanian's contributions to the field of pharmaceuticals through his patents and work at Bristol-Myers Squibb Company highlight his role as an influential inventor. His innovations in integrin inhibitors have the potential to address significant health challenges.